Status:
COMPLETED
Bone Marrow Cells in Myocardial Infarction
Lead Sponsor:
University of Oulu
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study is aimed to assess the effect of bone marrow cells on arrhythmia risk variables in patients with a acute myocardial infarction.
Detailed Description
This is a randomized, double-blinded study, where patients treated with thrombolytic therapy for acute myocardial infarction are randomized to receive bone-marrow derived stem cells or sham-infusion a...
Eligibility Criteria
Inclusion
- Acute ST-elevation myocardial infarction treated with thrombolytic therapy
Exclusion
- Indication for rescue PCI, severe clinical heart failure, age \<18 years
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00363324
Start Date
January 1 2005
End Date
November 1 2007
Last Update
January 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oulu
Oulu, Finland, 90220